Triple Threat – 3x Retatrutide 10MG Research Pack

Triple Threat: 3x Retatrutide 10MG Research Bundle

This research bundle includes three (3) vials of Retatrutide 10MG, a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. Retatrutide has generated significant interest in metabolic research due to its novel tri-agonist mechanism of action.

Bundle Contents

• 3x Retatrutide 10MG lyophilized powder
• Each vial independently tested for purity and identity

Research Context

Retatrutide (LY3437943) is a novel investigational compound studied for its simultaneous activity at three incretin-related receptors. Published Phase 2 trial data has demonstrated dose-dependent effects in preclinical and clinical research settings. This triple-agonist approach represents a distinct mechanism compared to single or dual-agonist compounds.

Purity & Testing

All Maple Research peptides undergo third-party COA testing. Certificates of Analysis are available on individual product pages.

Storage

Store lyophilized powder at -20°C for long-term storage or 2-8°C for short-term. Protect from light and moisture.

Shipping

Same-day shipping on orders placed before 12 PM EST. Ships across Canada.

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.

For peer-reviewed research on this topic, visit PubMed.